(Cash Covers Puts, this is not a naked Option.)
ONTY
@ $7.00
Sell to Open, ONTY January 2012
$5.00
Put @
.30c
Limit
Good until cancelled
How to do this trade Video:
http://www.youtube.com/watch?v=Vx4i9ob4HmM
$10,000 would return $600.00 in 11 days
Oncothyreon Inc.(ONTY), a clinical

stage biopharmaceutical company, focuses on the
development of therapeutic products for the treatment of cancer. Its primary product
candidate, S
timuvax is in Phase III clinical trials for the treatment of non

small cell
lung cancer. The company also develops PX

866, a small molecule that is in Phase II
trials. In addition, it engages in the preclinical development of ONT

10, a cancer
vaccine. The
company operates in Canada, the United States, Barbados, and Europe.
Oncothyreon Inc. was founded in 1985 and is headquartered in Seattle, Washington.
Quote:
“In the business world, the rear view mirror is always clearer than
the windshield. “
~
Warren Buffet
Until Next Time
Brad Lee
The Options Oracle

Greetings and Welcome aboard to all
new subscribers.
Congrats to all with successful trades.
“*IMPORTANT*
Please review our definitions in order
to get acquainted with language we
will be using”
https://theoptionsoracle.com/glossary

Feel free to look at our past issues
because ma
ny trades last multiple
months.
https://theoptionsoracle.com/past-performance

Links to the actual trades is
HERE

Company News
Auto Trading is now active!
Don’t want to be bothered doing the
trades?
Auto

trading is for you. Your account
will automatically do whatever I do.
You are still in control, you set the
limits either a dollar amount or a
percentage.
Go to the main site, the Auto

trade
link is on the right
https://theoptionsoracle.com/
Disclosure: These are my actual
trade
s.
Your subscription fee may be
100%
TAX DEDUCTIBLE
if used for
educational business/investment
purposes.
Check with your Licensed
Professional adviser
Options involve risk and are not suitable
for all investors. Prior to trading options,
you must be approved for options
trading and read the Characteristics
and Risks of Standardized Op
tions.
Copies of this document may also be
obtained from your broker, from any
exchange on which options are traded, by
placing an order online, or by contacting
the Options Clearing Corporation directly
at 1 N. Wacker Dr., Suite 500, Chicago, IL
60606. (
1

888

678

4667).
Brad Lee AKA “The Options Oracle”
and “The Money Medic” is an
individual investor who does not
manage money for any financial
institution.You are purchasing the list
of stocks that he uses to select
options contracts he feels will ret
urn
him the highest, safest profits. Brad is
not a broker, or financial adviser. He
is a remarkable investor who has
developed a successful strategy for
himself, and is willing to share some
of his magic with you. We urge you
to paper trade these picks an
d learn
how to develop a strategy that is
appropriate for you.Thank You.
We
make no recommendations on
investment and we do not provide
financial, tax or legal advice. Content
and tools are provided for educational
and informational purposes only.
Disc
laimer
Trading or investment in stocks, futures &
options, and commodity are subject to potential
market risks. You can use our materials or
recommendations for educational purposes,
this is not intended as Trading or Investment
advice.
We are not financ
ial advisers. We
cannot provide any advice as to whether or not
options or our trading ideas are suitable
investments for your particular financial
situation. We are in the business of publishing
our trade ideas for market analysis only. We
highly recommen
d that our subscribers review
their trading allocation with a qualified
registered financial adviser/planner.
Legal Disclaimer: we do not exist to render and
do not give legal, tax, economic or investment
advice and disclaims all liability for the actions
or inaction taken or not as a result of
communications from or to its members,
officers, directors, employees and contractors.
Each individual should consult his/her own
counsel, accountant and other advisors as to
legal, tax, economic, investment and rel
ated
matters concerning any type of investments.
This email and any files transmitted with it
are solely intended for the use of the
addressee(s) and may contain information
that is confidential and privileged. If you
receive this email in error, please
advise us
by return email immediately. Please also
disregard the contents of the email, delete it
and destroy any copies immediately.